Zidas Medtech Private Limited, a completely owned subsidiary of Zidas LifeSieces Limited, has a strategic partnership with Braille Biomedica, a new Brazil -based in Brazil, Brazil.
The purpose of this partnership is to particularly commercialize its transcatator and valve transplant technology in Europe, India and other select markets. The agreement is an important step in the strategic expansion of Zides Medtech in the rapidly growing interventional cardiology sector. The global Tavi market size is currently about 6 billion dollars, which is observing a strong growth due to increasing cases of aortic stenosis and increasing demand for minimum aggressive heart processes.
Dr. Sharvil Patel, Managing Director of Zidas LifeSyinsage Limited, said, “We are proud to partner with Braille to expand access to modern and important heart care around the world and improve the results for patients.” This will provide the latest and state -of -the -art technology minimum aggressive approach, which will give patients to the faster recovery, short -term stay in the hospital and the quality of better life.
The Post Business: Zidas Medtech signed the agreement with Brazil’s Brazil’s Brazil’s first appeared on News India Live | Breaking India News, The Indian Headline, India Express News, Fast India News.
